RES complex GO:0070274: Components, Assembly and Research Methods

The RES complex (pre-mRNA REtention and Splicing complex) is a conserved nuclear protein complex that plays a dual role in RNA processing: it promotes efficient splicing of pre-mRNA and prevents the export of unspliced transcripts from the nucleus. First identified in Saccharomyces cerevisiae, the complex is composed of three core subunits—Ist3p, Bud13p, and Pml1p—and is essential for maintaining the fidelity of gene expression. Because splicing defects are associated with a wide range of human diseases, including cancer and neurodegeneration, understanding the RES complex has become a priority for researchers in RNA biology and molecular medicine. The RES complex functions at the interface of splicing and nuclear export, acting as a quality-control checkpoint that ensures only fully processed mRNAs reach the cytoplasm. Its subunits interact with spliceosomal components and nuclear pore proteins, coordinating the timing of intron removal with the licensing of mRNA export. This coupling is critical for preventing the translation of aberrant proteins that could disrupt cellular homeostasis. In recent years, CRISPR-based gene editing has emerged as a powerful tool to study the RES complex in human cells and model organisms. By generating knockout, point-mutation, knock-in, and overexpression models, researchers can dissect the precise contributions of each subunit to splicing, nuclear retention, and disease pathogenesis. This article provides a comprehensive overview of the RES complex, its components, mechanisms, and the experimental approaches used to study it.

The RES complex is a protein complex that is required for efficient splicing and prevents leakage of unspliced pre-mRNAs from the nucleus. It is named for pre-mRNA REtention and Splicing. In Saccharomyces, the complex consists of Ist3p, Bud13p, and Pml1p.

The RES complex is essential for maintaining the integrity of the transcriptome by coupling splicing with nuclear retention and export. Its dysfunction leads to the accumulation of unspliced or aberrantly spliced mRNAs, which can be translated into toxic proteins or trigger cellular stress responses. Because alternative splicing is a hallmark of higher eukaryotes and its dysregulation is implicated in numerous diseases, the RES complex represents a critical node for understanding gene expression control and for developing RNA-targeted therapeutics.

The following genes and proteins are key components or interactors of the RES complex, based on published literature.

The RES complex is regulated at multiple levels. Its subunit expression can be controlled transcriptionally and post-translationally. Phosphorylation of Bud13p and Ist3p may modulate complex assembly and activity. The complex's interaction with the spliceosome is dynamic and regulated by splicing signals and cellular conditions. Additionally, nuclear pore components and export factors influence RES complex function.

Dysregulation of splicing factors, including RES complex components, is increasingly recognized in cancer. Mutations in spliceosomal genes such as SF3B1, U2AF1, and SRSF2 are common in myeloid malignancies and solid tumors. The RES complex, by ensuring splicing fidelity, may act as a tumor suppressor; its loss could contribute to aberrant splicing and oncogenesis.

Defects in RNA processing, including splicing and nuclear retention, are linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The RES complex may influence the accumulation of misprocessed RNAs that form toxic aggregates.

Mutations in spliceosomal components cause developmental disorders, including craniofacial anomalies and intellectual disability. The RES complex, as a splicing regulator, could be involved in such conditions, though direct evidence is still emerging.

RNA-seq is used to assess global changes in splicing and intron retention upon RES complex perturbation. Knockout or knockdown of RES complex subunits followed by RNA-seq reveals unspliced transcripts and alternative splicing events. This method provides a transcriptome-wide view of RES complex function.

Affinity purification coupled with mass spectrometry (AP-MS) identifies RES complex interactors. Proximity labeling (BioID) can map the interactome in living cells. These approaches reveal dynamic interactions with spliceosomal and nuclear pore components.

Fluorescence microscopy of tagged RES complex subunits reveals their nuclear localization and dynamics. Single-molecule imaging can track pre-mRNA retention and export. These methods link RES complex function to nuclear architecture.

Genome-wide CRISPR knockout screens can identify genes that synergize with RES complex loss. Such screens uncover pathways that buffer splicing defects and may reveal therapeutic targets. Bioinformatics analysis of screening data prioritizes candidate genes.

Researchers studying RES complex-related genes often need to determine whether a candidate gene is causally involved in splicing regulation, nuclear retention, or disease pathogenesis. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models, enabling functional validation and drug discovery.

The RES complex (GO:0070274) is a critical regulator of splicing and nuclear retention, with conserved functions from yeast to humans. Its study offers insights into fundamental RNA processing mechanisms and their roles in disease. CRISPR-based models and advanced omics technologies are accelerating discoveries in this field, and EDITGENE is committed to supporting researchers with tailored gene editing solutions.